Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 8/2014

01-12-2014

Placenta-breast cancer cell interactions promote cancer cell epithelial mesenchymal transition via TGFβ/JNK pathway

Authors: Gali Epstein Shochet, Shelly Tartakover-Matalon, Liat Drucker, Metsada Pasmanik-Chor, Meir Pomeranz, Ami Fishman, Michael Lishner

Published in: Clinical & Experimental Metastasis | Issue 8/2014

Login to get access

Abstract

Women diagnosed with pregnancy associated breast cancer often have advanced cancer with metastases and reduced expression of ERα compared to non-pregnant women. Nevertheless, metastases to the placenta are uncommon. Previously, we demonstrated that breast cancer cells (MCF-7/T47D) migrated from ex vivo human placental explant implantation sites. We aimed to analyze the effect of factors produced during placental implantation or as a result of the interaction between the implanted placentae to cancer cells on cancer cells migration and aggressiveness. We collected supernatants from implanted placentae and placental-breast cancer cells cocultures and analyzed their effects on cancer cells phenotype and pathways. Supernatants collected from breast cancer cells served as controls. We found that supernatants collected from implanted placentae induced modest cancer cells migration that was not accompanied by epithelial to mesenchymal transition (EMT), supported breast cancer cells survival and elevated MCF-7 cell number. The coculture supernatant induced excessive motility and EMT of the MCF-7 cells. This EMT was mediated by Smad3 and JNK/ERK activation. Both placenta and coculture supernatants reduced ERα expression in the cancer cells. Finally, we showed that MCF-7 cocultured with the human placental explants underwent continuous activation of JNK and Smad3 pathways and the EMT process, which led to their migration away from the placental implantation sites. These findings may explain the reduced ERα and elevated metastases found in breast cancer during pregnancy and highlights pathways involved in it.
Literature
1.
Stensheim H, Moller B, Van Dijk T, Fossa SD (2009) Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 27(1):45–51PubMedCrossRef
2.
Van Calsteren K, Heyns L, De Smet F, Van Eycken L, Gziri MM, Van Gemert W, Halaska M, Vergote I, Ottevanger N, Amant F (2010) Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol 28(4):683–689PubMedCrossRef
3.
Pavlidis NA (2002) Coexistence of pregnancy and malignancy. Oncologist 7(4):279–287PubMed
4.
Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Burke B, Sutcliffe SB, Koren G (1992) Maternal and fetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol 166(3):781–787PubMedCrossRef
5.
Gasim T, Al Dakhiel SA, Al Ghamdi AA, Al Ali M, Al Jama F, Rahman J, Al Suleiman SA, Rahman MS (2010) Ovarian tumors associated with pregnancy: a 20-year experience in a teaching hospital. Arch Gynecol Obstet 282(5):529–533PubMedCrossRef
6.
Ulery M, Carter L, Mcfarlin BL, Giurgescu C (2009) Pregnancy-associated breast cancer: significance of early detection. J Midwife Womens Health 54(5):357–363CrossRef
7.
Amant F, Von Minckwitz G, Han SN, Bontenbal M, Ring AE, Giermek J, Wildiers H, Fehm T, Linn SC, Schlehe B, Neven P, Westenend PJ, Muller V, Van Calsteren K, Rack B, Nekljudova V, Harbeck N, Untch M, Witteveen PO, Schwedler K, Thomssen C, Van Calster B, Loibl S (2013) Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol 31(20):2532–2539PubMedCrossRef
8.
Cardonick E, Dougherty R, Grana G, Gilmandyar D, Ghaffar S, Usmani A (2010) Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J 16(1):76–82PubMedCrossRef
9.
Genin AS, Lesieur B, Gligorov J, Antoine M, Selleret L, Rouzier R (2012) Pregnancy-associated breast cancers: do they differ from other breast cancers in young women? Breast 21(4):550–555PubMedCrossRef
10.
Baulies S, Cusido M, Tresserra F, Rodriguez I, Ubeda B, Ara C, Fabregas R (2014) Pregnancy-Associated Breast Cancer: an analytical observational study. Med Clin (Barc) 142(5):200–204CrossRef
11.
Madaras L, Kovacs KA, Szasz AM, Kenessey I, Tokes AM, Szekely B, Baranyak Z, Kiss O, Dank M, Kulka J (2013) Clinicopathological features and prognosis of pregnancy associated breast cancer—a matched case control study. Pathol Oncol Res 20:581–590PubMedCrossRef
12.
Johansson AL, Andersson TM, Hsieh CC, Cnattingius S, Lambe M (2011) Increased mortality in women with breast cancer detected during pregnancy and different periods postpartum. Cancer Epidemiol Biomarkers Prev 20(9):1865–1872PubMedCrossRef
13.
Ali SA, Gupta S, Sehgal R, Vogel V (2012) Survival outcomes in pregnancy associated breast cancer: a retrospective case control study. Breast J 18(2):139–144PubMedCrossRef
14.
Dimitrakakis C, Zagouri F, Tsigginou A, Marinopoulos S, Sergentanis TN, Keramopoulos A, Zografos GC, Ampela K, Mpaltas D, Papadimitriou C, Dimopoulos MA, Antsaklis A (2013) Does pregnancy-associated breast cancer imply a worse prognosis? A matched case-case study. Breast Care (Basel) 8(3):203–207CrossRef
15.
Shousha S (2000) Breast carcinoma presenting during or shortly after pregnancy and lactation. Arch Pathol Lab Med 124(7):1053–1060PubMed
16.
Pilewskie M, Gorodinsky P, Fought A, Hansen N, Bethke K, Jeruss J, Scholtens D, Khan SA (2012) Association between recency of last pregnancy and biologic subtype of breast cancer. Ann Surg Oncol 19(4):1167–1173PubMedCrossRef
17.
Platet N, Cathiard AM, Gleizes M, Garcia M (2004) Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 51(1):55–67PubMedCrossRef
18.
Zeng Q, Li W, Lu D, Wu Z, Duan H, Luo Y, Feng J, Yang D, Fu L, Yan X (2012) CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer. Proc Natl Acad Sci U S A 109(4):1127–1132PubMedCentralPubMedCrossRef
19.
Zaretsky JZ, Barnea I, Aylon Y, Gorivodsky M, Wreschner DH, Keydar I (2006) MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression. Mol Cancer 5:57PubMedCentralPubMedCrossRef
20.
Woo JC, Yu T, Hurd TC (2003) Breast cancer in pregnancy: a literature review. Arch Surg 138(1):91–98 (discussion 99)PubMedCrossRef
21.
Lukanova A, Surcel HM, Lundin E, Kaasila M, Lakso HA, Schock H, Husing A, Kaaks R, Koskela P, Grankvist K, Pukkala E, Zeleniuch-Jacquotte A, Lehtinen M, Toniolo P (2012) Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer. Int J Cancer 130(4):910–920PubMedCentralPubMedCrossRef
22.
Haughian JM, Pinto MP, Harrell JC, Bliesner BS, Joensuu KM, Dye WW, Sartorius CA, Tan AC, Heikkila P, Perou CM, Horwitz KB (2012) Maintenance of hormone responsiveness in luminal breast cancers by suppression of Notch. Proc Natl Acad Sci USA 109(8):2742–2747PubMedCentralPubMedCrossRef
23.
Tartakover-Matalon S, Mizrahi A, Epstein G, Shneifi A, Drucker L, Pomeranz M, Fishman A, Radnay J, Lishner M (2010) Breast cancer characteristics are modified by first trimester human placenta: in vitro co-culture study. Hum Reprod 25(10):2441–2454PubMedCrossRef
24.
Holtan SG, Creedon DJ, Haluska P, Markovic SN (2009) Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents. Mayo Clin Proc 84(11):985–1000PubMedCentralPubMedCrossRef
25.
Genbacev Olga, Schubach Stephanie A, Miller Richard K (1992) Villous culture of first trimester human placenta-model to study extravillous trophoblast (EVT) differentiation. Placenta 13(5):439–461PubMedCrossRef
26.
Genbacev O, Jensen KD, Powlin SS, Miller RK (1993) In vitro differentiation and ultrastructure of human extravillous trophoblast (EVT) cells. Placenta 14(4):463–475PubMedCrossRef
27.
Shochet Epstein (2012) G., S. Tartakover Matalon, L. Drucker, M. Pomeranz, A. Fishman, G. Rashid, V. Oron-Karni, M. Pasmanik-Chor, and M. Lishner, Hormone-dependent placental manipulation of breast cancer cell migration. Hum Reprod 27(1):73–88CrossRef
28.
Chu Y-W, Wang R, Schmid I, Sakamoto M (1999) Analysis with flow cytometry of green fluorescent protein expression in leukemic cells. Cytometry 36(4):333–339PubMedCrossRef
29.
Keller A, Backes C, Al-Awadhi M, Gerasch A, Kuntzer J, Kohlbacher O, Kaufmann M, Lenhof HP (2008) GeneTrailExpress: a web-based pipeline for the statistical evaluation of microarray experiments. BMC Bioinformatics 9:552PubMedCentralPubMedCrossRef
30.
Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z (2009) GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 10:48PubMedCentralPubMedCrossRef
31.
Na YR, Seok SH, Kim DJ, Han JH, Kim TH, Jung H, Lee BH, Park JH (2009) Bone morphogenetic protein 7 induces mesenchymal-to-epithelial transition in melanoma cells, leading to inhibition of metastasis. Cancer Sci 100(11):2218–2225PubMedCrossRef
32.
Drabsch Y, Ten Dijke P (2011) TGF-beta signaling in breast cancer cell invasion and bone metastasis. J Mammary Gland Biol Neoplas 16(2):97–108CrossRef
33.
Al Saleh S, Al Mulla F, Luqmani YA (2011) Estrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cells. PLoS ONE 6(6):e20610PubMedCentralPubMedCrossRef
34.
Band AM, Laiho M (2011) Crosstalk of TGF-beta and estrogen receptor signaling in breast cancer. J Mammary Gland Biol Neopl 16(2):109–115CrossRef
35.
Pereg D, Koren G, Lishner M (2008) Cancer in pregnancy: gaps, challenges and solutions. Cancer Treat Rev 34(4):302–312PubMedCrossRef
36.
Jackisch C, Louwen F, Schwenkhagen A, Karbowski B, Schmid KW, Schneider HP, Holzgreve W (2003) Lung cancer during pregnancy involving the products of conception and a review of the literature. Arch Gynecol Obstet 268(2):69–77PubMed
37.
38.
Liu Q, Zhang Y, Mao H, Chen W, Luo N, Zhou Q, Yu X (2012) A crosstalk between the Smad and JNK signaling in the TGF-beta-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells. PLoS ONE 7(2):e32009PubMedCentralPubMedCrossRef
39.
Velden JL, Alcorn JF, Guala AS, Badura EC, Janssen-Heininger YM (2011) c-Jun N-terminal kinase 1 promotes transforming growth factor-beta1-induced epithelial-to-mesenchymal transition via control of linker phosphorylation and transcriptional activity of Smad3. Am J Respir Cell Mol Biol 44(4):571–581PubMedCentralPubMedCrossRef
40.
41.
Kalkhoven E, Roelen BA, De Winter JP, Mummery CL, Van Den Eijnden-Van Raaij AJ, Van Der Saag PT, Van Der Burg B (1995) Resistance to transforming growth factor beta and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differ 6(9):1151–1161PubMed
42.
Chen L, Mayer JA, Krisko TI, Speers CW, Wang T, Hilsenbeck SG, Brown PH (2009) Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells. Cancer Res 69(23):8853–8861PubMedCentralPubMedCrossRef
43.
Coradini D, Fornili M, Ambrogi F, Boracchi P, Biganzoli E (2012) TP53 mutation, epithelial–mesenchymal transition, and stemlike features in breast cancer subtypes. J Biomed Biotechnol 2012:254085PubMedCentralPubMedCrossRef
44.
45.
Manaster I, Goldman-Wohl D, Greenfield C, Nachmani D, Tsukerman P, Hamani Y, Yagel S, Mandelboim O (2012) MiRNA-mediated control of HLA-G expression and function. PLoS ONE 7(3):e33395PubMedCentralPubMedCrossRef
Metadata
Title
Placenta-breast cancer cell interactions promote cancer cell epithelial mesenchymal transition via TGFβ/JNK pathway
Authors
Gali Epstein Shochet
Shelly Tartakover-Matalon
Liat Drucker
Metsada Pasmanik-Chor
Meir Pomeranz
Ami Fishman
Michael Lishner
Publication date
01-12-2014
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 8/2014
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-014-9683-0

Other articles of this Issue 8/2014

Clinical & Experimental Metastasis 8/2014 Go to the issue

Research Paper

CCR1-mediated accumulation of myeloid cells in the liver microenvironment promoting mouse colon cancer metastasis

OriginalPaper

Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer

Research Paper

Targeting IL-6 and RANKL signaling inhibits prostate cancer growth in bone

Review

Improving treatment strategies for patients with metastatic castrate resistant prostate cancer through personalized computational modeling

Research Paper

TGFβ can stimulate the p38/β-catenin/PPARγ signaling pathway to promote the EMT, invasion and migration of non-small cell lung cancer (H460 cells)

Research Paper

Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits